These compounds may interact with:

Tissue-type plasminogen activator

Potentially involved in: carcinoma; cerebrovascular disease; myocardial infarction; pulmonary embolism; coronary thrombosis; heart disease; thrombophilia; intermediate coronary syndrome; hypertension; post-thrombotic syndrome; atherosclerosis; cancer; diabetes mellitus; aphasia; brain ischemia; peripheral vascular disease; angioedema; kidney disease; hepatic veno-occlusive disease; autosomal recessive nonsyndromic deafness 77

Disease data sourced from Pharos.